Kato H - Search Results

1

Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.

Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Ojima H, Tsukada K, Oriuchi N, Inoue T, Endo K. Kato H, et al. Cancer. 2002 Feb 15;94(4):921-8. Cancer. 2002. PMID: 11920459 Free article.

2

Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma.

Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H. Nakajima M, et al. Among authors: kato h. Cancer Lett. 2002 Apr 8;178(1):99-106. doi: 10.1016/s0304-3835(01)00825-4. Cancer Lett. 2002. PMID: 11849747

3

Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.

Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H. Fukuchi M, et al. Among authors: kato h. Cancer. 2002 Aug 15;95(4):737-43. doi: 10.1002/cncr.10727. Cancer. 2002. PMID: 12209716 Free article.

4

Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer.

Kato H, Kuwano H, Nakajima M, Miyazaki T, Yoshikawa M, Masuda N, Fukuchi M, Manda R, Tsukada K, Oriuchi N, Endo K. Kato H, et al. Am J Surg. 2002 Sep;184(3):279-83. doi: 10.1016/s0002-9610(02)00932-7. Am J Surg. 2002. PMID: 12354600

5

EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.

Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. Miyazaki T, et al. Among authors: kato h. Int J Cancer. 2003 Feb 20;103(5):657-63. doi: 10.1002/ijc.10860. Int J Cancer. 2003. PMID: 12494475

6

High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma.

Fukuchi M, Fukai Y, Masuda N, Miyazaki T, Nakajima M, Sohda M, Manda R, Tsukada K, Kato H, Kuwano H. Fukuchi M, et al. Among authors: kato h. Cancer Res. 2002 Dec 15;62(24):7162-5. Cancer Res. 2002. PMID: 12499250

7

Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H. Kato H, et al. Anticancer Res. 2002 Sep-Oct;22(5):2635-9. Anticancer Res. 2002. PMID: 12529975

8

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Kato H, et al. Anticancer Res. 2002 Nov-Dec;22(6C):3977-84. Anticancer Res. 2002. PMID: 12553021

9

Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma.

Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T, Kuwano H. Fukai Y, et al. Among authors: kato h. Int J Cancer. 2003 Mar 20;104(2):161-6. doi: 10.1002/ijc.10929. Int J Cancer. 2003. PMID: 12569570

10

Distinctive clinicopathological characteristics in esophageal squamous cell carcinoma.

Kuwano H, Nakajima M, Miyazaki T, Kato H. Kuwano H, et al. Among authors: kato h. Ann Thorac Cardiovasc Surg. 2003 Feb;9(1):6-13. Ann Thorac Cardiovasc Surg. 2003. PMID: 12667124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,159 results

Search Page

Filters